MT-TP and metabolic dysfunction-associated steatotic liver disease: In addition to demonstrating the functional consequences of the MTTP p.I564T variant, the HLCs derived from hiPSCs provide a disease model for early-stage NAFLD, beyond triglyceride accumulation.